- ISO 17025 lab-tested
- 99%+ purity
- Research use only
RETAVA PEN - Retatrutide 30mg
-
Processed as soon as payment clears
Packed and dispatched without delay.
-
Free shipping over €99.00 to most EU countries
-
Shipment protection included
Lost or damaged in transit? We send a replacement.
-
Discreet packaging
Plain parcel, no product names on the outside.
-
We accept
Secure checkout
- SEPA bank transfer
Independent lab results
Tested before it reaches your bench
Every batch is analysed by an independent, ISO 17025-accredited laboratory before release. The report shown here belongs to the batch now shipping, so what you read is what you receive.
Analiza Białek sp. z o.o.
ISO/IEC 17025 accredited
HPLC purity
99%
Release minimum: 99%
- Lot
- RT10/012026
- Tested
- July 2, 2026
- Measured
- 10.51 mg
- Report no.
- D57K1Z9U
- Batch-specific
- Independent lab
Quality control results
1 passed · 1 reported-
Purity
Reversed-phase HPLC
99% Pass -
Net peptide content
HPLC quantitation
10.51 mg Reported
Tests in our panel
- Visual inspection · Colour, form and integrity of the lyophilised powder and the vial seal, checked against the specification.
- LC-MS · Confirms the molecular mass matches the expected structure of the compound.
- Impurity profile · Checks for residues from synthesis and handling that should not be present.
- Elemental analysis · Screens for toxic metals that can enter through raw materials or equipment.
- Microbial culture · Checks a sample for bacterial and fungal growth.
- Endotoxin assay · Measures bacterial endotoxins, reported in endotoxin units (EU) per vial.
All published batches
Every lot of this product we have released, each with its own certificate. Newest first.
RETAVA PEN - Retatrutide 30mg
LatestLOT RT10/012026
99%
HPLC purity
- Measured content
- 10.51 mg
- Tested on
- July 2, 2026
2 assays by Analiza Białek sp. z o.o.
Open certificate
About this compound
RETAVA Retatrutide 30 mg Pen – Easy-to-Use Triple Agonist
The RETAVA Retatrutide 30 mg Pen offers a simple, convenient, and precise way to work with Retatrutide in research settings. As a triple GLP-1/GIP/GCGR agonist, Retatrutide is one of the most advanced and powerful compounds for studies involving metabolic regulation, appetite signaling, glucose control, and body-weight modulation.
Applications
Suitable for:
- Glucose metabolism and insulin sensitivity
- Appetite and satiety pathways
- Body-weight regulation
- Comparative studies with multiagonists and GLP-1 analogs
Included in the Package
- 1x RETAVA Retatrutide 30 mg Pen in premium box
- 12x Pen needles (compatible and individually sealed)
- Printed instructions integrated on the inside of the box for quick and easy guidance
Research notice
For laboratory research use only. This product is not a medicinal product or a food. It is not intended for human or veterinary use, or for any diagnostic or therapeutic purpose.
The buyer is responsible for receiving, storing, handling and disposing of this material safely and lawfully, in line with the rules of their country and institution. We sell only to adults aged 18 or over who are qualified to work with research materials.
Descriptions on this page summarise published research for educational purposes. They are not medical advice and make no claim about safety or effects in humans.
